NASDAQ NMS - GLOBAL MARKET · RNAC
+1.78% · +$0.1400 · Vol 211.1K
Market closed · last close 4:00 PM ET · price as of 18:29:33 ET
Cartesian Therapeutics Inc

Cartesian Therapeutics Inc

Biotechnology
$8.00
Card
Relationship Map

Follow $RNAC

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $RNAC by email

Veridion Score

BETALOW CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
RNAC
Cartesian Therapeutics Inc
Sat Sep 19 · market closed · Markets closed · resumes Mon 9:30 ET
Lowest range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

20/ 100
Veridion Score
Lowest range · LOW confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5 of 6 factors measured · Sat Sep 19 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is RNAC moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading RNAC catalysts
About Cartesian Therapeutics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2016
Employees
75
Country
US

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$7.88
Day high
$8.26
Day low
$7.66
Previous close
$7.86
52W high
$10.59
-24.46% from high
52W low
$5.84
45% of range
Market cap
$243M
EPS
$-1.1000
Beta
1.04
Shares out
30.3M
Volume
211.1K
1.80× rel vol
Avg volume
117.2K
VWAP
$7.95
Price history computed in-house
1W
-2.32%
1M
-21.80%
3M
-16.93%
1Y
-15.25%
YTD
+10.96%
SMA 50 $8.71 · below
SMA 200 $7.72 · above
52W position 45%

RNAC overview

Veridion Score
20
Registered · 2026-09-18
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around RNAC.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading RNAC Form 4 filings
Public disclosures

Congress activity in RNAC

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for RNAC in the cached public ledger.

Federal contracts

RNAC contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for RNAC in this window.
Lobbying spend

RNAC lobbying filings, year to date.

Registered lobbying filings matched to Cartesian Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for RNAC in this window.
Loading news for RNAC
Analyst ratings
Sovereign unlock shows live analyst consensus for RNAC.
Options
Sovereign unlock shows live options positioning for RNAC.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.